Cargando…

Macrophages protect mycoplasma‐infected chronic myeloid leukemia cells from natural killer cell killing

Macrophages (Mϕ) have been reported to downmodulate the cytotoxicity of natural killer (NK) cell against solid tumor cells. However, the collaborative role between NK cells and Mϕ remains underappreciated, especially in hematological cancers, such as chronic myeloid leukemia (CML). We observed a hig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choo, Qing Wei Winnie, Koean, Ricky Abdi Gunawan, Chang, Shu‐Chun, Chng, Wee Joo, Chan, Ming Chun, Wang, Wilson, Er, Jun Zhi, Ding, Jeak Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027758/ https://www.ncbi.nlm.nih.gov/pubmed/31837284 http://dx.doi.org/10.1111/imcb.12309

Ejemplares similares

Loss of T‐bet confers survival advantage to influenza–bacterial superinfection
por: Er, Jun Zhi, et al.
Publicado: (2018)

Novel AU-rich proximal UTR sequences (APS) enhance CXCL8 synthesis upon the induction of rpS6 phosphorylation
por: Ang, Zhiwei, et al.
Publicado: (2019)

Lung Cancer Induces NK Cell Contractility and Cytotoxicity Through Transcription Factor Nuclear Localization
por: Wong, Darren Chen Pei, et al.
Publicado: (2022)

pHLuc, a Ratiometric Luminescent Reporter for in vivo Monitoring of Tumor Acidosis
por: Ong, Tiffany T., et al.
Publicado: (2020)

Resistance to FLT3 inhibitors in acute myeloid leukemia: Molecular mechanisms and resensitizing strategies
por: Zhou, Jianbiao, et al.
Publicado: (2018)

Off-the-shelf CAR–engineered natural killer cells targeting FLT3 enhance killing of acute myeloid leukemia
por: Mansour, Anthony G., et al.
Publicado: (2023)

The role of natural killer cells in chronic myeloid leukemia
por: Danier, Anna Carolyna Araújo, et al.
Publicado: (2011)

Targeted Killing of Monocytes/Macrophages and Myeloid Leukemia Cells with Pro-Apoptotic Peptides
por: Sioud, Mouldy, et al.
Publicado: (2019)

Killing the killers
por: De Paepe, Marianne, et al.
Publicado: (2014)

X‐linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery
por: Zhou, Jianbiao, et al.
Publicado: (2017)

Programmed differentiated natural killer cells kill leukemia cells by engaging SLAM family receptors
por: Wu, Yang, et al.
Publicado: (2017)

Natural killer cell-based immunotherapy for acute myeloid leukemia
por: Xu, Jing, et al.
Publicado: (2020)

Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: from molecular pathogenesis to therapeutic target
por: Zhou, Jianbiao, et al.
Publicado: (2015)

LEE011 and ruxolitinib: a synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)
por: Hee, Yan Ting, et al.
Publicado: (2018)

TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells
por: Lelaidier, Martin, et al.
Publicado: (2015)

Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia
por: Zhou, Jianbiao, et al.
Publicado: (2017)

How cells kill a "killer" messenger
por: Saveanu, Cosmin, et al.
Publicado: (2016)

Clinical Impact of Percentage of Natural Killer Cells and Natural Killer-Like T Cell Population in Acute Myeloid Leukemia
por: Jamal, Esraa, et al.
Publicado: (2020)

Single-cell genomic profiling of acute myeloid leukemia for clinical use: A pilot study
por: Yan, Benedict, et al.
Publicado: (2017)

Prognostically relevant natural killer cell-mediated immunoediting in acute myeloid leukemia
por: Chan, Christopher J, et al.
Publicado: (2013)

BET Bromodomain inhibition promotes De-repression of TXNIP and activation of ASK1-MAPK pathway in acute myeloid leukemia
por: Zhou, Yafeng, et al.
Publicado: (2018)

Dendrogenin A Synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo
por: Serhan, Nizar, et al.
Publicado: (2020)

The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation
por: de Mel, Sanjay, et al.
Publicado: (2018)

The BH3-mimetic ABT-737 effectively kills acute myeloid leukemia initiating cells
por: Baev, Denis V., et al.
Publicado: (2014)

Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells
por: Dulphy, Nicolas, et al.
Publicado: (2016)

Acute Myeloid Leukemia Epigenetic Immune Escape From Nature Killer Cells by ICAM-1
por: Xiao, Yang, et al.
Publicado: (2021)

PVRIG is a novel natural killer cell immune checkpoint receptor in acute myeloid leukemia
por: Li, Jessica, et al.
Publicado: (2020)

Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Cianga, Vlad Andrei, et al.
Publicado: (2021)

Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication.
por: Foreman, N. K., et al.
Publicado: (1993)

Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms
por: Tan, Ming, et al.
Publicado: (2019)

Secreted β(3)-Integrin Enhances Natural Killer Cell Activity against Acute Myeloid Leukemia Cells
por: Skaik, Younis, et al.
Publicado: (2014)

Alloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive Immunotherapy
por: Ruggeri, Loredana, et al.
Publicado: (2015)

Haploidentical Natural Killer Cell Therapy as an Adjunct to Stem Cell Transplantation for Treatment of Refractory Acute Myeloid Leukemia
por: Kulkarni, Uday, et al.
Publicado: (2023)

Hiltonol Cocktail Kills Lung Cancer Cells by Activating Cancer-Suppressors, PKR/OAS, and Restraining the Tumor Microenvironment
por: Chang, Shu-Chun, et al.
Publicado: (2021)

Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells
por: Cieniewicz, Brandon, et al.
Publicado: (2020)

Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells
por: Wu, Chun-Hua, et al.
Publicado: (2019)

Killing a Killer: What Next for Smallpox?
por: McFadden, Grant
Publicado: (2010)

Natural killers shed attachments to kill again
por: Felce, James H., et al.
Publicado: (2018)

Serial Killing of Tumor Cells by Human Natural Killer Cells – Enhancement by Therapeutic Antibodies
por: Bhat, Rauf, et al.
Publicado: (2007)

Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells
por: Panwong, Suthida, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1f9bqsf1oju92b9qe7otume2kg